Market Research Report
Breast Biopsy Market Research Report by Product, by Type, by Guidance, by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19
|Published by||360iResearch LLP||Product code||982358|
|Published||Content info||197 Pages
Delivery time: 1-2 business days
|Breast Biopsy Market Research Report by Product, by Type, by Guidance, by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19|
|Published: February 4, 2021||Content info: 197 Pages||
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
Market Segmentation & Coverage:
This research report categorizes the Breast Biopsy to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product, the Breast Biopsy Market studied across Assay Kits, Biopsy Needles, Biopsy Tables, Guidance Systems, Liquid Biopsy Instruments, and Localization Wires.
Based on Type, the Breast Biopsy Market studied across Liquid Breast Biopsy, Needle Breast Biopsy, and Open Surgical Breast Biopsy. The Liquid Breast Biopsy further studied across Circulating Tumor Cells and Circulating Tumor DNA. The Needle Breast Biopsy further studied across Core Needle Biopsy, Fine Needle Aspiration Biopsy, and Vacuum-Assisted Biopsy. The Open Surgical Breast Biopsy further studied across Excisional and Incisional.
Based on Guidance, the Breast Biopsy Market studied across Image-Guided Biopsy and Liquid Biopsy. The Image-Guided Biopsy further studied across Mammography-Guided Stereotactic Biopsy, MRI Guided Biopsy, and Ultrasound-Guided Biopsy. The Liquid Biopsy further studied across Microarray-Based Biopsy, NGS-Based Biopsy, and PCR-Based Biopsy.
Based on Application, the Breast Biopsy Market studied across Early Cancer Screening, Recurrence Monitoring, Therapy Selection, and Treatment Monitoring.
Based on Geography, the Breast Biopsy Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Breast Biopsy Market including Argon Medical Devices, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biocept, Inc., Cardiff Oncology, Inc., Cook Medical Incorporated, Danaher Corporation, Encapsule Medical Devices, LLC, Ethicon Endo-Surgery, EXACT Sciences Corporation, F. Hoffmann-La Roche AG, Fluxion Biosciences, Inc., Gallini S.r.l., Hologic, Inc., Illumina, Inc., IZI Medical Products, LLC, Leica Biosystems Nussloch GmbH, Medtronic PLC, Menarini Silicon Biosystems, S.p.A., Merit Medical Systems, Inc., Myriad Genetics, Inc., QIAGEN, Scion Medical Technologies, LLC, STERYLAB S.r.l., and Thermo Fisher Scientific.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch™ FPNV Positioning Matrix:
The 360iResearch™ FPNV Positioning Matrix evaluates and categorizes the vendors in the Breast Biopsy Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch™ Competitive Strategic Window:
The 360iResearch™ Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch™ Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
The report answers questions such as: